Familial Hypercholesterolemia and Cardiovascular Outcomes Amongst Younger Patients Undergoing Coronary Bypass Surgery
FH is highly prevalent among younger patients undergoing coronary bypass surgery. These patients are less likely to achieve adequate LDL reduction and are at higher risk of further adverse events. Detection and appropriate treatment of FH prior to bypass surgery should be a clinical priority.
Authors
- J. Andrew Black (ORCID: https://orcid.org/0000-0003-0406-2500)
- Warrick Bishop (ORCID: https://orcid.org/0000-0002-9323-2665)
- Carmel Fenton
- C. Lees
- Ashutosh Hardikar (ORCID: https://orcid.org/0000-0003-3558-6454)
- Lauren Dare
- Gerald F. Watts (ORCID: https://orcid.org/0000-0003-2276-1524)
- James E. Sharman (ORCID: https://orcid.org/0000-0003-2792-0811)
- Olivia G Deconinck
- T. D. Pointon
Institutions
- University of Tasmania (AU)
- The University of Western Australia (AU)
- Royal Hobart Hospital (AU)
- Calvary Hospital (AU)
Publication Details
- Journal
- Heart Lung and Circulation
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1016/j.hlc.2024.08.001
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.57